Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07505342 · ClinicalTrials.gov registry record
Remote Assessments and Genetic Determinants of Myotonic Dystrophy
A clinical trial, sponsored by University of Rochester.
- Recruiting
- Registry status
- 1,000
- Enrollment target
NCT07505342: Recruiting study, sponsored by University of Rochester.
NCT07505342 is a clinical trial that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07505342 is actively recruiting participants, sponsored by University of Rochester.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
The goal of this observational study, conducted in participants' homes and requiring no travel to a study site, is to better understand disease variability in people with myotonic dystrophy type 1 (DM1) and to identify effective ways to measure symptoms. Myotonic dystrophy is one of the most variable diseases. Some people develop symptoms when they are young, others when they are much older. In the same family, some people may have mild problems, while others are strongly affected. The goal of this study is to find out more about what is causing these differences. To accomplish this, investigators will study the effects of DM1 on skeletal and smooth muscles, the heart, and the nervous system. Then, investigators will evaluate genetic differences with a blood sample. * Participants will receive a toolkit in the mail which includes all necessary equipment to participate in the study, including an iPad with video conferencing software. * Then the study team will connect with participants via videoconferencing for medical interview about DM1 symptoms and functional assessments * Participants will have their blood drawn in a lab in their community or using a home draw device, and ship it to us for research genetic analysis * Participants can chose to have their research genetic test result returned to them
Primary Outcome
Grip strength will be assessed using a hand held dynamometer (strength measured in kg)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2022-05-10 |
| Est. Completion | 2030-01-01 |
What NCT07505342 shows while recruiting
NCT07505342 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT07505342 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07505342 about?
NCT07505342 is a clinical study titled "Remote Assessments and Genetic Determinants of Myotonic Dystrophy". The goal of this observational study, conducted in participants' homes and requiring no travel to a study site, is to better understand disease variability in people with myotonic dystrophy type 1 (DM1) and to identify effective ways to measure symptoms. Myotonic dystrophy is one of the most variab...
What is the current status of trial NCT07505342?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2022-05-10. Estimated completion is 2030-01-01.
Who is sponsoring clinical trial NCT07505342?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI